The Australian Atherosclerosis Society (AAS) is a non-profit association formed in 1974 that promotes the advancement of science, research and clinical management in the field of atherosclerosis. The AAS is internationally recognised and hosted both the 1986 and 2012 International Symposia on Atherosclerosis. AAS members have significant international profiles in both the clinical and scientific spheres. A special interest of the AAS is familial hypercholesterolaemia (FH). The AAS established the FH Australasia Network and Registry and is committed to preventing early heart attacks in people with inherited high cholesterol by promoting education, research and best clinical practice.

The Australian Atherosclerosis Society (AAS) recognises that honesty, integrity, respect, fairness, and embracing differences are fundamental to achieving the advancement of learning and knowledge. The AAS strives, through continuous improvement, to integrate equal opportunity principles into all aspects of its activities through its decision-making and planning processes. Through this policy the AAS seeks to promote the principles of equal opportunity; gender equity, cultural diversity, fairness and social justice and to act in accordance with relevant legislation.